Arbutus Biopharma Corporation (ABUS)

[Ron1303]

Hello Karin. Also begs the questions:
1.- Why was such a POS Pr made public, no quality control?
2.- Why was it so poorly written & the motives behind this?

A few days ago we had Maxim lower the price to $14 because they chose not value to HBV assets at all. Maxim seemed to have had an excellent relationship with the old TKMR management.

And now we have this Pr sabotage the perception of one of our assets that made up the new $14 share price.

So today the market decided to shave 80-100 millon of the market cap because now these Ebola assets are put in doubt.

Who remains longer in the saddle with a collapsing share price, MM or Vivek?